Literature DB >> 18930545

[Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings].

F Bing1, S Kremer, L Lamalle, S Chabardes, A Ashraf, B Pasquier, J-F Le Bas, A Krainik, S Grand.   

Abstract

PURPOSE: Pilocytic astrocytomas (PA) and hemangioblastomas (HB) can present the same morphological characteristics on conventional MRI sequences, most usually in the form of a cerebellar cystic mass with a mural nodule that strongly enhances on post-contrast T1 images. We discuss here the value of perfusion MRI in the differentiation of these two tumors, the diagnoses of which have already been histopathologically established.
METHOD: Eleven patients with PA and eight with HB underwent first-pass perfusion MRI. The maximum relative cerebral blood volume (rCBV(max)), defined as the ratio between the CBV(max) in tumor tissue and the CBV in healthy, contralateral white matter, is considered to be indicative of the type of tumor.
RESULTS: The difference between the rCBV(max) of PA (rCBV(max)=1.19+/-0.71, range 0.6-3.27) compared with that of HB (rCBV(max)=9.37+/-2.37, range 5.38-13) was significant (P<0.001). The first-pass curve crossed the baseline, corresponding to vascular permeability problems in both PA and HB.
CONCLUSION: The first-pass method of perfusion MRI is a quick and useful way to differentiate between PA and HB.

Entities:  

Mesh:

Year:  2008        PMID: 18930545     DOI: 10.1016/j.neurad.2008.09.002

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  7 in total

1.  High accuracy of arterial spin labeling perfusion imaging in differentiation of pilomyxoid from pilocytic astrocytoma.

Authors:  S A Nabavizadeh; R Assadsangabi; M Hajmomenian; M Santi; A Vossough
Journal:  Neuroradiology       Date:  2015-02-10       Impact factor: 2.804

2.  Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging.

Authors:  D She; X Yang; Z Xing; D Cao
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

3.  Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.

Authors:  D J She; Z Xing; Z Zeng; X Y Shang; D R Cao
Journal:  Neuroradiology       Date:  2014-12-07       Impact factor: 2.804

Review 4.  Surgical resection of sporadic and hereditary hemangioblastoma: Our 10-year experience and a literature review.

Authors:  Elisabeth Bründl; Petra Schödel; Odo-Winfried Ullrich; Alexander Brawanski; Karl-Michael Schebesch
Journal:  Surg Neurol Int       Date:  2014-09-22

5.  The role of diffusion and perfusion magnetic resonance imaging in differentiation of haemangioblastomas and pilocytic astrocytomas.

Authors:  Małgorzata Neska-Matuszewska; Anna Zimny; Joanna Bladowska; Anna Czarnecka; Marek Sąsiadek
Journal:  Pol J Radiol       Date:  2018-05-10

6.  A solitary hemangioblastoma of the posterior brain fossa: the role of radiotherapy.

Authors:  Fatima Zahra Abboud; Moulay Ali Youssoufi; Touria Bouhafa; Khalid Hassouni
Journal:  Pan Afr Med J       Date:  2020-06-19

7.  Advanced magnetic resonance imaging findings of cerebellar hemangioblastomas: A report of three cases and a literature review.

Authors:  Eiji Matsusue; Chie Inoue; Sadaharu Tabuchi; Hiroki Yoshioka; Yuichiro Nagao; Kensuke Matsumoto; Kazuhiko Nakamura; Shinya Fujii
Journal:  Acta Radiol Open       Date:  2022-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.